AMYLASEPOLYPEPTIDE

European patent · EP3783103 · In force

Register entry

Publication number
EP3783103
Application number
EP20198751
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 19, 2010
Published
Feb 24, 2021
Granted
Mar 30, 2022
Protection ends at the latest
May 18, 2030
Next annual fee due
May 31, 2026
IPC classes
C12N 9/28 (2006.01)
C12P 19/14 (2006.01)
Priority
EP 09160655 19.05.2009
US 17952509 P 19.05.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  2. Jun 3, 2024

    Address changed

    Owner
    DuPont Nutrition Biosciences ApS, Langebrogade 1, 1411 Copenhagen K, Denmark → International N&H Denmark ApS, Langebrogade 1, 1411 Copenhagen K, Denmark

    Published in Swissreg on 03.06.2024

  3. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  4. Jun 1, 2023

    Change

    Published in Swissreg on 01.06.2023

  5. Mar 7, 2023

    Change

    Published in Swissreg on 07.03.2023

  6. Mar 30, 2022

    Granted

    Published in Swissreg on 30.03.2022

Parties

Holder

International N&H Denmark ApS

Langebrogade 1, 1411 Copenhagen K, DK

Inventor

KRAGH, Karsten Matthias

1411 Copenhagen K, DK

MIKKELSEN, René

8732 Hovedgaard, DK

JENNER, Rikke L. Bundgaard

8471 Sabro, DK

MEJLDAL, Rie

8752 Østbirk, DK

KELLET-SMITH, Anja Hemmingsen

1411 Copenhagen K, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.